Clinical Trial Update: Azacitidine in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating azacitidine in patients with previously treated advanced non-small cell lung cancer; trial completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2013-09-13